Skip to main content

Table 6 Determinants of high-density lipoprotein cholesterol in young adulthood (N = 594 personsa)

From: Tracking of serum lipids from prepuberty to young adulthood: results from the KiGGS cohort study

 

Male (N = 306)

Female (N = 288)

bivariable

multivariable

bivariable

multivariable

Beta (95% CI)

R2

Beta (95% CI)

R2

Beta (95% CI)

R2

Beta (95% CI)

R2

Baseline HDL cholesterol

0.39 (0.31; 0.48)***

0.32

0.38 (0.29; 0.47)***

0.37

0.47 (0.30; 0.63)***

0.19

0.46 (0.28; 0.63)***

0.27

HFD index in childhood

0.26 (0.06; 0.46)*

0.02

0.20 (-0.06; 0.46)

0.11 (-0.26; 0.49)

 < 0.01

0.21 (-0.19; 0.61)

HFD index in young adulthood

-0.16 (-0.37; 0.05)

 < 0.01

0.00 (-0.22; 0.21)

0.17 (-0.11; 0.44)

 < 0.01

0.27 (-0.06; 0.59)

Physical activity in childhood

 

0.01

  

 < 0.01

 

 Low

-0.08 (-0.19; 0.03)

 

-0.01 (-0.10; 0.07)

-0.02 (-0.17; 0.13)

 

0.02 (-0.11;0.14)

 Middle

-0.06 (-0.12; 0.00)

 

-0.05 (-0.11; 0.01)

0.04 (-0.05; 0.14)

 

0.05 (-0.04; 0.13)

 High

ref

 

ref

ref

 

ref

Sports (h per week) in young adulthood

0.01 (0.00;0.02)*

0.02

0.00 (-0.01; 0.01)

0.00 (-0.02; 0.01)

 < 0.01

-0.01 (-0.02; 0.01)

Oral contraceptives use in young adulthood

-

-

-

-

0.17 (0.07; 0.26)***

0.06

0.16 (0.07; 0.24)***

  1. The regression model includes BMI z-score in childhood and difference in BMI z-score in young adulthood, healthy food diversity index in childhood and change in young adulthood, physical activity in childhood, sports in young adulthood, smoking in young adulthood, alcohol use in young adulthood and oral contraceptive use in young adulthood. Variables explaining less than 1% of the variance in both sexes are not shown in the tables of the main manuscript. The full model is shown in Additional file 2
  2. a6–8 years of age at KiGGS baseline and ≥ 18 + years at KiGGS wave 2
  3. *p < 0.05, **p < 0.01, ***p < 0.001